Covance Company Profile (NYSE:CVD)

About Covance (NYSE:CVD)

Covance logoCovance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:CVD
  • CUSIP: 22281610
  • Web: www.covance.com
Average Prices:
  • 50 Day Moving Avg: $97.00
  • 200 Day Moving Avg: $92.00
  • 52 Week Range: $58.00 - $107.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.20
  • P/E Growth: 0
Profitability:
  • Net Margins: 7.70%
  • Return on Equity: 12.64%
  • Return on Assets: 8.17%
Misc:
  • Average Volume: 187,762 shs.
 
Frequently Asked Questions for Covance (NYSE:CVD)

What is Covance's stock symbol?

Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD."

How were Covance's earnings last quarter?

Covance Inc. (NYSE:CVD) released its quarterly earnings data on Wednesday, February, 4th. The company reported $0.97 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.97. The firm earned $634 million during the quarter, compared to the consensus estimate of $631.30 million. Covance had a return on equity of 12.64% and a net margin of 7.70%. View Covance's Earnings History.

Who are some of Covance's key competitors?

How do I buy Covance stock?

Shares of Covance can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covance's stock price today?

One share of Covance stock can currently be purchased for approximately $106.00.


MarketBeat Community Rating for Covance (NYSE CVD)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  252
MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Covance (NYSE:CVD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Covance (NYSE:CVD)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Covance (NYSE:CVD)
Earnings by Quarter for Covance (NYSE:CVD)
Earnings History by Quarter for Covance (NYSE CVD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/4/2015Q414$0.97$0.97$631.30 million$634.00 millionViewN/AView Earnings Details
11/3/2014Q314$0.98$0.98$651.00 million$627.00 millionViewN/AView Earnings Details
7/29/2014Q214$0.93$0.95$639.80 million$687.10 millionViewN/AView Earnings Details
5/1/2014Q114$0.90$0.90$632.01 million$620.10 millionViewN/AView Earnings Details
2/4/2014Q413$0.84$0.87$613.80 million$623.00 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.77$0.78$586.12 million$644.00 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.72$0.75$569.34 million$580.20 millionViewN/AView Earnings Details
1/24/2013Q4 2012$0.71$0.73$548.84 million$562.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.67$0.72$546.52 million$597.66 millionViewN/AView Earnings Details
7/25/2012$0.64$0.65ViewN/AView Earnings Details
5/2/2012$0.60$0.68ViewN/AView Earnings Details
1/25/2012$0.73$0.73ViewN/AView Earnings Details
11/2/2011$0.70$0.71ViewN/AView Earnings Details
7/27/2011$0.65$0.66ViewN/AView Earnings Details
5/5/2011$0.58$0.60ViewN/AView Earnings Details
1/26/2011$0.53$0.56ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Covance (NYSE:CVD)
Current Year EPS Consensus Estimate: $4 EPS
Next Year EPS Consensus Estimate: $5 EPS

Dividends

Dividend History for Covance (NYSE:CVD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Covance (NYSE:CVD)
Insider Trades by Quarter for Covance (NYSE:CVD)
Insider Trades by Quarter for Covance (NYSE:CVD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/22/2014Brian H NuttInsiderSell1,127$103.51$116,655.77View SEC Filing  
12/18/2014Joseph L HerringCEOSell32,692$103.02$3,367,929.84View SEC Filing  
12/10/2014John E WatsonVPSell15,200$102.94$1,564,688.00View SEC Filing  
9/9/2014Joseph L HerringCEOSell32,200$85.13$2,741,186.00View SEC Filing  
2/20/2014James LovettVPSell14,955$102.47$1,532,438.85View SEC Filing  
2/10/2014Brian NuttInsiderSell1,808$100.12$181,016.96View SEC Filing  
2/10/2014Richard CiminoEVPSell13,000$99.10$1,288,300.00View SEC Filing  
2/10/2014Sandra HeltonDirectorSell2,800$99.03$277,284.00View SEC Filing  
9/20/2013Richard CiminoEVPSell16,000$84.86$1,357,760.00View SEC Filing  
9/5/2013Sandra L HeltonDirectorSell3,000$81.92$245,760.00View SEC Filing  
9/5/2013William E KlitgaardVPSell25,323$81.44$2,062,305.12View SEC Filing  
8/21/2013Deborah KellerEVPSell15,900$83.12$1,321,608.00View SEC Filing  
8/16/2013Robert BarchiDirectorSell13,667$82.78$1,131,354.26View SEC Filing  
8/2/2013Gary CostleyDirectorSell7,467$82.77$618,043.59View SEC Filing  
8/2/2013Joseph HerringCEOSell100,000$82.54$8,254,000.00View SEC Filing  
6/27/2013Joseph L HerringCEOSell13,259$77.00$1,020,943.00View SEC Filing  
6/19/2013Joseph L HerringCEOSell22,391$78.03$1,747,169.73View SEC Filing  
5/15/2013James W LovettVPSell10,259$77.00$789,943.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Covance (NYSE:CVD)
Latest Headlines for Covance (NYSE:CVD)
Source:
DateHeadline
americanbankingnews.com logoCovance (CVD) Getting Very Positive News Coverage, Study Finds
www.americanbankingnews.com - April 29 at 9:00 AM
americanbankingnews.com logoSomewhat Positive Press Coverage Very Likely to Affect Covance (CVD) Share Price
www.americanbankingnews.com - April 25 at 5:24 PM
seekingalpha.com logoLabCorp extends process improvement initiative to Covance, $30M charge planned to cover costs associated with job cuts and facility closures; shares slip 4%
seekingalpha.com - April 25 at 3:58 PM
americanbankingnews.com logoSomewhat Negative Press Coverage Extremely Likely to Affect Covance (CVD) Share Price
www.americanbankingnews.com - April 22 at 8:05 AM
thestreet.com logoINC Research Holdings Seen as Likely LabCorp. Takeover Target
us.rd.yahoo.com - December 12 at 12:12 PM
seekingalpha.com logoINC Research: Strong quarter boosts bull thesis, bodes well for pharma services peers
seekingalpha.com - October 31 at 10:28 AM
finance.yahoo.com logoLabCorp (LH) Q3 Earnings Miss, Revenues in Line; Guides Up
finance.yahoo.com - October 26 at 4:33 PM
finance.yahoo.com logoCovance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running
au.finance.yahoo.com - October 12 at 9:49 PM
finance.yahoo.com logoLabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
finance.yahoo.com - July 27 at 1:16 PM
finance.yahoo.com logoLabCorp Sees Balanced Growth; Covance Synergy on Track
finance.yahoo.com - June 21 at 7:00 AM
finance.yahoo.com logoLabCorp (LH) Posts Strong Q1; Covance Synergy Continues
finance.yahoo.com - May 17 at 8:07 AM
finance.yahoo.com logoEarly Development, Central Labs Businesses: Strong Demand in 1Q16
finance.yahoo.com - May 8 at 7:05 AM
seekingalpha.com logoINC Research Holdings In The Spotlight As Rumors Of A Suitor Circulate
seekingalpha.com - May 3 at 7:14 AM
finance.yahoo.com logoLabCorp (LH) Tops Q1 Earnings and Sales, Raises Guidance
finance.yahoo.com - April 25 at 10:02 AM
bloomberg.com logoTesting LabCorp's Deal Plans
www.bloomberg.com - April 19 at 11:00 AM
finance.yahoo.com logoLabCorp (LH): Revenues Strong on Balanced Organic Growth
finance.yahoo.com - February 23 at 4:13 PM
bizjournals.com logoLabCorp's King: 2015 was 'transformative'
www.bizjournals.com - February 18 at 1:00 PM
finance.yahoo.com logoLabCorp Q4 Earnings Miss, Revenues Top; Currency Bothers
finance.yahoo.com - February 18 at 11:02 AM
finance.yahoo.com logoLabCorp Tops Revenues, Misses on Earnings in Q4
finance.yahoo.com - February 18 at 7:45 AM
finance.yahoo.com logoWill LabCorp (LH) Disappoint Earnings Estimates in Q4?
finance.yahoo.com - February 15 at 1:00 PM
finance.yahoo.com logoLabCorp Poised on Strategic Initiatives, Currency Woes Linger
finance.yahoo.com - January 5 at 2:35 PM
finance.yahoo.com logoLabCorp (LH) Posts Mixed Q3, Covance Synergy on Track
finance.yahoo.com - December 1 at 2:15 PM
thestreet.com logoLaboratory Corp. of America (LH) Stock Gains on Earnings Beat
www.thestreet.com - October 26 at 3:57 PM
bizjournals.com logoCovance deal continues to fuel revenue, earnings growth for LabCorp
www.bizjournals.com - October 26 at 2:00 PM
finance.yahoo.com logoLabCorp Q3 Earnings in Line, Revenues Strong; View Revised
finance.yahoo.com - October 26 at 9:50 AM
finance.yahoo.com logoLabCorp (LH) Q3 Earnings in Line, Revenues Beat Estimates
finance.yahoo.com - October 26 at 8:10 AM
wsj.com logo[$$] LabCorp's Sales Soars Following Covance Buy
www.wsj.com - October 26 at 7:51 AM
bizjournals.com logoLabCorp expands beyond labwork with purchase of food and beverage company
www.bizjournals.com - October 23 at 2:20 PM
thestreet.com logoLaboratory Corp Of America (LH) Earnings Report: Q2 2015 Conference Call Transcript
www.thestreet.com - July 28 at 5:39 PM
finance.yahoo.com logoWill LabCorp (LH) Keep its Earnings Streak Alive in Q2? - Analyst Blog
finance.yahoo.com - July 24 at 2:25 PM
finance.yahoo.com logoKeyBanc Starts Lab Corp Of America At Overweight, But Indebtedness Is A Concern
finance.yahoo.com - June 16 at 10:45 AM

Social

Chart

Covance (CVD) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff